Chen TJ - Search Results

1

Concurrent metastatic thymic carcinoma and postirradiation sarcoma.

Chen TJ, Lu HI, Huang CH, Hsu HC, Chen ST, Chen WJ, Huang CC. Chen TJ, et al. Among authors: chen st, chen wj. Ann Thorac Surg. 2012 Apr;93(4):1295-6. doi: 10.1016/j.athoracsur.2011.09.046. Ann Thorac Surg. 2012. PMID: 22450080

2

Overexpression of CPS1 is an independent negative prognosticator in rectal cancers receiving concurrent chemoradiotherapy.

Lee YY, Li CF, Lin CY, Lee SW, Sheu MJ, Lin LC, Chen TJ, Wu TF, Hsing CH. Lee YY, et al. Among authors: chen tj. Tumour Biol. 2014 Nov;35(11):11097-105. doi: 10.1007/s13277-014-2425-8. Epub 2014 Aug 7. Tumour Biol. 2014. PMID: 25099619

3

Overexpression of REG4 confers an independent negative prognosticator in rectal cancers receiving concurrent chemoradiotherapy.

He HL, Lee YE, Shiue YL, Lee SW, Lin LC, Chen TJ, Wu TF, Hsing CH, Huang HY, Wang JY, Li CF. He HL, et al. Among authors: chen tj. J Surg Oncol. 2014 Dec;110(8):1002-10. doi: 10.1002/jso.23764. Epub 2014 Aug 22. J Surg Oncol. 2014. PMID: 25155043

4

Over-Expression of CHD4 Is an Independent Biomarker of Poor Prognosis in Patients with Rectal Cancers Receiving Concurrent Chemoradiotherapy.

Wang HC, Chou CL, Yang CC, Huang WL, Hsu YC, Luo CW, Chen TJ, Li CF, Pan MR. Wang HC, et al. Among authors: chen tj. Int J Mol Sci. 2019 Aug 21;20(17):4087. doi: 10.3390/ijms20174087. Int J Mol Sci. 2019. PMID: 31438571 Free PMC article.

5

Overexpression of Dehydrogenase/Reductase 9 Predicts Poor Response to Concurrent Chemoradiotherapy and Poor Prognosis in Rectal Cancer Patients.

Chen TJ, Hsu BH, Lee SW, Yang CC, Tian YF, Kuo YH, Li WS, Tsai HH, Wu LC, Yeh CF, Chou CL, Lai HY. Chen TJ, et al. Pathol Oncol Res. 2022 Oct 6;28:1610537. doi: 10.3389/pore.2022.1610537. eCollection 2022. Pathol Oncol Res. 2022. PMID: 36277959 Free PMC article.

6

Rsf-1/HBXAP overexpression is associated with disease-specific survival of patients with gallbladder carcinoma.

Chen TJ, Huang SC, Huang HY, Wei YC, Li CF. Chen TJ, et al. APMIS. 2011 Nov;119(11):808-14. doi: 10.1111/j.1600-0463.2011.02808.x. Epub 2011 Sep 22. APMIS. 2011. PMID: 21995635

7

TOP2A overexpression as a poor prognostic factor in patients with nasopharyngeal carcinoma.

Lan J, Huang HY, Lee SW, Chen TJ, Tai HC, Hsu HP, Chang KY, Li CF. Lan J, et al. Among authors: chen tj. Tumour Biol. 2014 Jan;35(1):179-87. doi: 10.1007/s13277-013-1022-6. Epub 2013 Jul 30. Tumour Biol. 2014. PMID: 23897556

8

PLA2G2A overexpression is associated with poor therapeutic response and inferior outcome in rectal cancer patients receiving neoadjuvant concurrent chemoradiotherapy.

He HL, Lee YE, Shiue YL, Lee SW, Lin LC, Chen TJ, Wu TF, Li CF. He HL, et al. Among authors: chen tj. Histopathology. 2015 Jun;66(7):991-1002. doi: 10.1111/his.12613. Epub 2015 Jan 13. Histopathology. 2015. PMID: 25393083

9

Characterization and Prognostic Significance of Methylthioadenosine Phosphorylase Deficiency in Nasopharyngeal Carcinoma.

He HL, Lee YE, Shiue YL, Lee SW, Chen TJ, Li CF. He HL, et al. Among authors: chen tj. Medicine (Baltimore). 2015 Dec;94(49):e2271. doi: 10.1097/MD.0000000000002271. Medicine (Baltimore). 2015. PMID: 26656376 Free PMC article.

10

Overexpression of the PSAT1 Gene in Nasopharyngeal Carcinoma Is an Indicator of Poor Prognosis.

Liao KM, Chao TB, Tian YF, Lin CY, Lee SW, Chuang HY, Chan TC, Chen TJ, Hsing CH, Sheu MJ, Li CF. Liao KM, et al. Among authors: chen tj. J Cancer. 2016 May 25;7(9):1088-94. doi: 10.7150/jca.15258. eCollection 2016. J Cancer. 2016. PMID: 27326252 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,323 results

Search Page

Filters